Pfizer to invest over $2.5B at Belgium, Ireland plants, Reuters reports

Pfizer plans to invest more than $2.5B to expand its drug manufacturing sites in Puurs, Belgium, and Dublin, Ireland, Reuters’ Michael Erman reports. "It is all aligned with the growth of our pipeline," Pfizer Chief Global Supply Officer Mike McDermott told Reuters. Pfizer hopes to introduce as many as 19 new medicines over the next year and a half, including treatments for ulcerative colitis and migraines, as well as its vaccine for RSV, the report notes. Reference Link